Optiver Holding
ARKG icon

Optiver Holding’s ARK Genomic Revolution ETF ARKG Stock Holding History

Optiver Holding’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,551
Closed -$126K – 2487
2025
Q3 		$126K Buy
+4,551
New +$115K ﹤0.01% 667
2022
Q2 		– Sell
-294
Closed -$14K – 365
2022
Q1 		$14K Sell
294
-596
-67% -$28.4K ﹤0.01% 405
2021
Q4 		$57K Buy
890
+672
+308% +$46.5K ﹤0.01% 397
2021
Q3 		$16K Sell
218
-627
-74% -$52.6K ﹤0.01% 492
2021
Q2 		$78K Buy
+845
New +$71.8K ﹤0.01% 255

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Optiver Holding's ARKG Position: Q4 2025 in Review

Optiver Holding sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 4,551 shares — an estimated $126K sold.

Optiver Holding first reported a position in ARKG in Q2 2021 and held it in 5 quarters. The position peaked at $126K in Q3 2025. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Optiver Holding reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Optiver Holding sold 4,551 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $126K.
  • Optiver Holding first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 5 quarters.
  • Optiver Holding's ARK Genomic Revolution ETF position peaked at $126K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.